New Guidance on Research Activities Effective June 21, 2021

June 3, 2021 (updated July 1, 2021)

Dear UMB Research Community:

We are pleased to announce the following updates regarding research operations effective Monday, June 21, 2021:

Campus Research Not Involving Human Subjects:  Laboratory-based research will be increased to 100 percent occupancy with no physical distancing requirements inside laboratories.Effective July 1, 2021, masks are not required to be worn by fully vaccinated students, faculty, and staff working in UMB laboratories.

Community-based Research: The current exclusion of Category D research in community settings will be lifted, with Stage 3 community-based research allowed to resume.  Researchers must follow all guidelines set by the collaborating entity (e.g., nursing home, school, community center, etc.). A letter from the collaborating entity stating that researchers are permitted to conduct studies in their facilities is required to be included as supporting documentation in a Reportable New Information (RNI) submission for the study, along with the required checklists found here.

Clinical Research and Other Campus Research Involving Human Subjects: Researchers conducting human subjects research will abide by the current University of Maryland Medical System (UMMS) guidelines for conducting clinical research.  UMMS guidelines currently state that researchers must wear masks, regardless of vaccination status, unless they are alone in their work space. There is no density requirement, but researchers should practice physical distancing where possible.

As COVID-19 case numbers continue to decline and the rate of vaccination continues to increase, we are pleased to move a step closer toward normal operations.  Information on COVID-19 vaccine requirements and where to get a COVID-19 vaccine can be found on UMB’s COVID 19 Vaccine webpage.

Best,

Laurie E. Locascio, Ph.D.

Vice President for Research, and Chair of COVID 19 Research Advisory Task Force

Margaret McCarthy, Ph.D.

Chair, Department of Pharmacology, School of Medicine, and Co-Chair of COVID 19 Research Advisory Task Force

Susan Buskirk, DM, MS

Vice President and Chief Accountability Officer